RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Jaguar Health Stock

Jaguar Health ROE 2024

Jaguar Health ROE

-8.32

Ticker

JAGX

ISIN

US47010C4096

WKN

A2PLYX

In 2024, Jaguar Health's return on equity (ROE) was -8.32, a -111.53% increase from the 72.23 ROE in the previous year.

Jaguar Health Aktienanalyse

What does Jaguar Health do?

Jaguar Health Inc. is a biopharmaceutical company based in San Francisco, California, focused on the development and commercialization of innovative plant-based medicines. The company's history dates back to the founding of Napo Pharmaceuticals in 2002, which was renamed Jaguar Animal Health in 2007 to focus on the development of animal medicines. In 2015, Jaguar Health then established a subsidiary named Napo Pharmaceuticals to focus on the development of plant-based medicines for human use. Jaguar Health's business model is based on the research and development of medicines derived from plant extracts, particularly from the rainforest region in South America. The company collaborates with local communities and government agencies to ensure sustainable use of these plant resources. An important aspect of the business model is also cooperation and partnership with other companies and organizations to accelerate research and development and facilitate the market launch of new medicines. Jaguar Health is divided into different divisions that focus on specific medical applications. One important division is HIV/AIDS research, where the company is investigating various plant extracts that can alleviate symptoms of the disease and inhibit the spread of the virus. Another division is oncology research, in which Jaguar Health is working on the development of plant-based compounds that can inhibit the growth of tumor cells and improve the quality of life for cancer patients. A particular focus of Jaguar Health is also the research of plant-based medicines for the treatment of gastrointestinal diseases. The company has already developed the drug Mytesi based on the Croton lechleri tree, which is used to treat diarrhea in HIV/AIDS patients. Mytesi was approved by the US Food and Drug Administration (FDA) in 2016 and is the first drug developed by the company to market. Other products and medicines that Jaguar Health is working on include the drug Canalevia for the treatment of gastrointestinal inflammation in dogs and cats, as well as the drug Neonorm, which aims to improve intestinal mobility in foals and other animal species. Overall, Jaguar Health is working on a wide range of plant-based medicines and compounds for the treatment of various diseases and ailments. The company relies on close collaboration with government agencies, local communities, and other companies to accelerate the development and commercialization of innovative medicines while ensuring sustainable use of natural resources. Jaguar Health ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Jaguar Health's Return on Equity (ROE)

Jaguar Health's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Jaguar Health's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Jaguar Health's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Jaguar Health’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Jaguar Health stock

What is the ROE (Return on Equity) of Jaguar Health this year?

The ROE of Jaguar Health this year is -8.32 undefined.

How has the Return on Equity (ROE) of Jaguar Health developed compared to the previous year?

The ROE of Jaguar Health has increased by -111.53% decreased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Jaguar Health?

A high ROE indicates that Jaguar Health generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Jaguar Health?

A low ROE can indicate that Jaguar Health is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Jaguar Health affect the company?

A change in ROE (Return on Equity) of Jaguar Health can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Jaguar Health?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Jaguar Health?

Some factors that can influence Jaguar Health's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Jaguar Health pay?

Over the past 12 months, Jaguar Health paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Jaguar Health is expected to pay a dividend of 0 USD.

What is the dividend yield of Jaguar Health?

The current dividend yield of Jaguar Health is .

When does Jaguar Health pay dividends?

Jaguar Health pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Jaguar Health?

Jaguar Health paid dividends every year for the past 0 years.

What is the dividend of Jaguar Health?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Jaguar Health located?

Jaguar Health is assigned to the 'Health' sector.

Wann musste ich die Aktien von Jaguar Health kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Jaguar Health from 7/31/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 7/31/2024.

When did Jaguar Health pay the last dividend?

The last dividend was paid out on 7/31/2024.

What was the dividend of Jaguar Health in the year 2023?

In the year 2023, Jaguar Health distributed 0 USD as dividends.

In which currency does Jaguar Health pay out the dividend?

The dividends of Jaguar Health are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

The Jaguar Health stock can be added to a savings plan with the following providers: Trade Republic

Andere Kennzahlen von Jaguar Health

Our stock analysis for Jaguar Health Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Jaguar Health Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.